Tribute Pharmaceuticals Canada Inc. Contracts & Agreements

Release of Security Interest in Intellectual Property, dated February 5, 2016, made by SWK in favor of Tribute, Tribute Pharmaceuticals US Inc. and Tribute Pharmaceuticals... (Filed With SEC on February 11, 2016)

Release of Security Interest in Canadian Intellectual Property, dated February 5, 2016, made by SWK in favor of Tribute (Filed With SEC on February 11, 2016)

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER AND ARRANGEMENT (Filed With SEC on December 8, 2015)

AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER AND ARRANGEMENT (Filed With SEC on December 8, 2015)

Asset Purchase Agreement, dated as of May 21, 2015, by and among Tribute Pharmaceuticals International Inc., Mutual Pharmaceutical Company, Inc. and Sun Pharmaceutical Industries,... (Filed With SEC on December 2, 2015)

Share Purchase Agreement, dated as of June 16, 2015, by and among Tribute Pharmaceuticals Canada Inc. and the shareholders of Medical Futures Inc (Filed With SEC on August 25, 2015)

Promissory Note issued in connection with the Acquisition on June 16, 2015 (Filed With SEC on August 25, 2015)

Consolidated, Amended and Restated Promissory Note, dated October 1, 2014 (Filed With SEC on August 14, 2015)

Distribution Agreement, dated December 1, 2006, between Medical Futures, Inc. and Colorado Biolabs, Inc (Filed With SEC on August 14, 2015)

Amendment No. 1, dated as of December 1, 2010, to Distribution Agreement, dated December 1, 2006, between Medical Futures, Inc. and Colorado Biolabs, Inc (Filed With SEC on August 14, 2015)

Addendum, dated November 19, 2014, to Distribution Agreement, dated December 1, 2006, as amended, between Medical Futures, Inc. and Colorado Biolabs, Inc (Filed With SEC on August 14, 2015)

SHARE PURCHASE AGREEMENT BETWEEN TRIBUTE PHARMACEUTICALS CANADA INC. AND PARDEEP NIJHAWAN AND NIDHI NIJHAWAN (Filed With SEC on June 22, 2015)

AGENCY AGREEMENT (Filed With SEC on June 22, 2015)

EXHIBIT B UNSECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on June 22, 2015)

Certificate No. 2015-___. SECURED SUBORDINATE DEBENTUREOFTRIBUTE PHARMACEUTICALS CANADA INC. TABLE OF CONTENTS (Filed With SEC on June 22, 2015)

ASSET PURCHASE AGREEMENT by and between TRIBUTE PHARMACEUTICALS INTERNATIONAL INC. and MUTUAL PHARMACEUTICAL COMPANY, INC. and SUN PHARMACEUTICAL INDUSTRIES, INC. Dated:May 21,... (Filed With SEC on May 28, 2015)

AGENCY AGREEMENT (Filed With SEC on May 28, 2015)

AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 3, 2015)

CONSULTING AGREEMENT (Filed With SEC on March 3, 2015)

Executive Employment Agreement between the Company and Rob Harris effective as of January 1, 2015 (Filed With SEC on February 2, 2015)

Executive Employment Agreement between the Company and Scott Langille effective as of January 1, 2015 (Filed With SEC on February 2, 2015)

Asset Purchase Agreement, dated as of October 2, 2014, by and among Tribute Pharmaceuticals Canada Inc. and Novartis AG and Novartis Pharma AG (Filed With SEC on December 9, 2014)

License Agreement, dated as of October 2, 2014, by and among Tribute Pharmaceuticals Canada Inc. and Novartis AG, Novartis Pharma AG and Novartis Pharmaceuticals Canada Inc (Filed With SEC on December 9, 2014)

FIRST AMENDMENT TO CREDIT AGREEMENT AND GUARANTEE (Filed With SEC on November 10, 2014)

Void after 5:00 p.m. (Toronto time) on the 1st day of October, 2019 (Filed With SEC on November 10, 2014)

INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on November 10, 2014)

WARRANT INDENTURE Providing for the Issue of Common Share Purchase Warrants BETWEEN TRIBUTE PHARMACEUTICALS CANADA INC. - and - EQUITY FINANCIAL TRUST COMPANY Dated as of July 15,... (Filed With SEC on November 10, 2014)

Void after 4:00 p.m. (Toronto time) on the 15th day of July, 2016. COMPENSATION OPTIONS (Filed With SEC on November 10, 2014)

Asset Purchase Agreement, dated as of October 2, 2014, by and among Tribute Pharmaceuticals Canada Inc. and Novartis AG and Novartis Pharma AG (Filed With SEC on October 8, 2014)

License Agreement, dated as of October 2, 2014, by and among Tribute Pharmaceuticals Canada Inc. and Novartis AG, Novartis Pharma AG and Novartis Pharmaceuticals Canada Inc (Filed With SEC on October 8, 2014)

UNDERWRITING AGREEMENT (Filed With SEC on June 27, 2014)

Promissory Note, dated February 4, 2014, in the aggregate principal amount of $2,000,000 (Filed With SEC on February 11, 2014)

Warrant to purchase 347,222 shares of the Companys common stock, dated February 4, 2014 (Filed With SEC on February 11, 2014)

Promissory Note, dated August 8, 2013, in the aggregate principal amount of $6,000,000 (Filed With SEC on August 14, 2013)

Warrant to purchase 755,794 shares of the Companys common stock, dated August 8, 2013 (Filed With SEC on August 14, 2013)

Executive Employment Agreement, effective December 1, 2011, by and between Stellar Pharmaceuticals Inc. and Rob Harris (Filed With SEC on April 12, 2013)

Executive Employment Agreement, effective December 1, 2011, by and between Stellar Pharmaceuticals Inc. and Scott Langille (Filed With SEC on April 12, 2013)

SECURED PROMISSORY NOTE (Filed With SEC on March 22, 2013)

WARRANT for the purchase of Common Shares of STELLAR PHARMACEUTICALS INC. (Existing under the laws of Ontario) (Filed With SEC on March 22, 2013)

AMENDED AND RESTATED SECURED PROMISSORY NOTE (Filed With SEC on March 22, 2013)

AMENDED AND RESTATED WARRANT for the purchase of Common Shares of TRIBUTE PHARMACEUTICALS CANADA INC. (Existing under the laws of Ontario) (Filed With SEC on March 22, 2013)

STELLAR PHARMACEUTICALS INC. AMENDED AND RESTATED STOCK OPTION PLAN (Filed With SEC on March 22, 2013)

Exhibit 10.24 1 2 3 4 (Filed With SEC on March 22, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 22, 2013)

GENERAL SECURITY AGREEMENT (Filed With SEC on March 22, 2013)

INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on March 22, 2013)

CANADIAN COLLATERAL PLEDGE AGREEMENT (Filed With SEC on March 22, 2013)

CONFIRMATION OF INTELLECTUAL PROPERTY IP SECURITY AGREEMENT (Filed With SEC on March 22, 2013)

MidCap Funding III, LLC 7255 Woodmont Ave., Suite 200 Bethesda, Maryland 20814 (Filed With SEC on March 22, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 14, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 14, 2013)

[SERIES A/B] COMMON STOCK PURCHASE WARRANT TRIBUTE PHARMACEUTICALS CANADA INC. Warrant Shares: [_______]Initial Exercise Date: March ____, 2013 (Filed With SEC on March 14, 2013)

Form of Securities Purchase Agreement (Filed With SEC on March 8, 2013)

Form of Registration Rights Agreement (Filed With SEC on March 8, 2013)

Form of Series A/B Warrant (Filed With SEC on March 8, 2013)

Form of Securities Purchase Agreement (Filed With SEC on March 5, 2013)

Form of Registration Rights Agreement (Filed With SEC on March 5, 2013)

Form of Series A/B Warrant (Filed With SEC on March 5, 2013)

Share Purchase Agreement, dated December 1, 2011, between Stellar Pharmaceuticals Inc., Elora Financial Management Inc., Mary-Ann Harris, Rob Harris and Scott Langille (Filed With SEC on February 11, 2013)

Loan Agreement, dated June 14, 2010, between Tribute Pharma Canada Inc. and the Bank of Montreal in the amount of CND$500,000 (Filed With SEC on February 11, 2013)

Executive Employment Agreement, effective December 1, 2011, by and between Stellar Pharmaceuticals Inc. and Rob Harris (Filed With SEC on February 11, 2013)

Executive Employment Agreement, effective December 1, 2011, by and between Stellar Pharmaceuticals Inc. and Scott Langille (Filed With SEC on February 11, 2013)

Consulting Agreement, effective December 1, 2011, by and between Stellar Pharmaceuticals Inc. and Arnold Tenney (Filed With SEC on February 11, 2013)

Amended and Restated Executive Employment Agreement, effective December 1, 2011, by and between Stellar Pharmaceuticals Inc. and Janice Clarke (Filed With SEC on February 11, 2013)

Security Agreement, dated June 14, 2010, by Tribute Pharma Canada Inc. in favor of the Bank of Montreal (Filed With SEC on February 11, 2013)

Page 1 of 2 (Filed With SEC on February 11, 2013)

Form of Extension of Expiry Time, dated April 5, 2012 (Filed With SEC on April 12, 2012)

LICENSE AGREEMENT This License Agreement made as of December 13, 2006 BETWEEN (Filed With SEC on December 22, 2006)

CONFIDENTIAL SUPPLY AGREEMENT Dated December 13, 2006 by and between STELLAR PHARMACEUTICALS INC. ("STELLAR") and WATSON PHARMA, INC. ("WATSON") SUPPLY AGREEMENT (Filed With SEC on December 22, 2006)

Category

Industry

Companies

Contracts

Tribute Pharmaceuticals Canada Inc. Contracts & Agreements